Evidence map›Paper›PMID 35407342›Full record

ArticleNanomaterials (Basel, Switzerland)2022

CO

Oyundari Tumurbaatar, Hristina Lazarova, Margarita Popova, Violeta Mitova, Pavletta Shestakova, Neli Koseva

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Nanoconfinement-Enhanced COMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Engineering of Silica Mesoporous Materials for COMaterials (Basel, Switzerland) · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oyundari TumurbaatarInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 9, 1113 Sofia, Bulgaria.
Hristina LazarovaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 9, 1113 Sofia, Bulgaria.ORCID 0000-0003-3810-326X
Margarita PopovaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 9, 1113 Sofia, Bulgaria.
Violeta MitovaInstitute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 103A, 1113 Sofia, Bulgaria.ORCID 0000-0002-2714-7980
Pavletta ShestakovaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 9, 1113 Sofia, Bulgaria.
Neli KosevaInstitute of Polymers, Bulgarian Academy of Sciences, Acad. G. Bonchev St., bl. 103A, 1113 Sofia, Bulgaria.ORCID 0000-0002-8445-8953

Funding

Ministry of Education and Science National Research Programme EPLUS: Low Carbon Energy for the Transport and Households, grant agreement D01-214/2018 and D01-321/18.12.2019.
6 · The paper itself

Abstract

SBA-15 and MCM-48 mesoporous silicas were modified with functionalized (3-aminopropyl)triethoxysilane (APTES) by using the post-synthesis method, thus introducing N- and P-containing groups to the pore surface. The structure of the newly synthesized modifiers (aldimine and aminophosphonate derivatives of (3-aminopropyl)triethoxysilane and their grafting onto the porous matrix were proved by applying multinuclear NMR and FTIR spectroscopies. The content of the grafted functional groups was determined via thermogravimetric analysis. The physicochemical properties of the adsorbent samples were studied by nitrogen physisorption and UV-Vis spectroscopy. The adsorption capacity of CO

Indexed as

aminophosphonateCO2 capturemodified mesoporous silicasSchiff base

Identifiers

PMID35407342
PMCPMC9000677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.